Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Recursion Pharmaceuticals Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
RXRX
Nasdaq
8731
https://www.recursion.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals (RXRX) Dips More Than Broader Market: What You Should Know
- Apr 17th, 2024 9:50 pm
Where Will Recursion Pharmaceuticals Be in 5 Years?
- Apr 17th, 2024 11:00 am
Recursion Appoints Najat Khan, PhD, as Chief R&D Officer and Chief Commercial Officer
- Apr 16th, 2024 12:00 pm
Biotech on a Budget: 7 Stocks Under $10 With Huge Potential
- Apr 15th, 2024 4:54 pm
Wall Street Favorites: 3 Cathie Wood Stocks With Strong Buy Ratings for April 2024
- Apr 15th, 2024 12:00 pm
Can Recursion Pharmaceuticals Stock Double in 5 Years? Here's What It Would Take.
- Apr 10th, 2024 9:50 am
The AI Advantage: 2 Healthcare Stocks at the Forefront of Innovation
- Apr 8th, 2024 1:00 pm
Is This Under-the-Radar Artificial Intelligence (AI) Stock a Buy?
- Apr 4th, 2024 12:45 pm
Recursion Pharmaceuticals Inc Director Blake Borgeson Sells 11,447 Shares
- Apr 4th, 2024 5:31 am
Down -26.36% in 4 Weeks, Here's Why Recursion Pharmaceuticals (RXRX) Looks Ripe for a Turnaround
- Apr 3rd, 2024 1:35 pm
Recursion to Participate in Upcoming Investor Conference
- Apr 2nd, 2024 12:00 pm
All You Need to Know About Recursion Pharmaceuticals (RXRX) Rating Upgrade to Buy
- Apr 1st, 2024 4:00 pm
Recursion Publishes Annual Environmental, Social and Governance Report
- Mar 26th, 2024 12:00 pm
Recursion Pharmaceuticals Inc Director Blake Borgeson Sells 20,054 Shares
- Mar 22nd, 2024 5:29 am
New COVID-Like Outbreak 'Matter Of When, Not If,' WHO Director Warns As Scientists Race To Prepare Using Artificial Intelligence
- Mar 18th, 2024 5:00 pm
Recursion Pharmaceuticals Inc CFO Michael Secora Sells 50,000 Shares
- Mar 15th, 2024 5:49 am
Recursion Announces Plans to Open New Office in London
- Mar 11th, 2024 8:00 am
Recursion Pharmaceuticals Stock Has 33% Upside, According to 1 Wall Street Analyst
- Mar 7th, 2024 3:28 pm
Recursion Hosts Second Annual Rare Disease Day Events for Utah’s Rare Disease Community
- Mar 1st, 2024 7:58 pm
Cathie Wood Just Bought These 3 Biotech Stocks. Should You Buy, Too?
- Mar 1st, 2024 7:00 pm
Scroll